Integral Health Asset Management LLC Purchases New Position

Integral Health Asset Management LLC acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 100,000 shares of the company’s stock, valued at approximately $4,523,000. Integral Health Asset Management LLC owned 0.13% of […]

Related Keywords

Arizona , United States , Samarth Kulkarni , Green Alpha Advisors , Venturi Wealth Management , Credit Suisse Group , Sg Americas Securities , Securities Exchange Commission , Barclays , Citigroup , Health Asset Management , Integral Health Asset Management , Free Report , State Retirement System , Wealth Management , Capital Management , Alpha Advisors , Suisse Group , Get Free Report , Exchange Commission , Crispr Therapeutics , Nasdaq Crsp , Crsp , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,